157 related articles for article (PubMed ID: 31729871)
1. A Self-Assembled Platform Based on Branched DNA for sgRNA/Cas9/Antisense Delivery.
Liu J; Wu T; Lu X; Wu X; Liu S; Zhao S; Xu X; Ding B
J Am Chem Soc; 2019 Dec; 141(48):19032-19037. PubMed ID: 31729871
[TBL] [Abstract][Full Text] [Related]
2. A Nucleic Acid/Gold Nanorod-Based Nanoplatform for Targeted Gene Editing and Combined Tumor Therapy.
Tang W; Han L; Lu X; Wang Z; Liu F; Li Y; Liu S; Liu S; Tian R; Liu J; Ding B
ACS Appl Mater Interfaces; 2021 May; 13(18):20974-20981. PubMed ID: 33909408
[TBL] [Abstract][Full Text] [Related]
3. Targeted delivery of CRISPR/Cas9 to prostate cancer by modified gRNA using a flexible aptamer-cationic liposome.
Zhen S; Takahashi Y; Narita S; Yang YC; Li X
Oncotarget; 2017 Feb; 8(6):9375-9387. PubMed ID: 28030843
[TBL] [Abstract][Full Text] [Related]
4. Branched Antisense and siRNA Co-Assembled Nanoplatform for Combined Gene Silencing and Tumor Therapy.
Liu J; Lu X; Wu T; Wu X; Han L; Ding B
Angew Chem Int Ed Engl; 2021 Jan; 60(4):1853-1860. PubMed ID: 33058467
[TBL] [Abstract][Full Text] [Related]
5. A DNA Origami-Based Gene Editing System for Efficient Gene Therapy in Vivo.
Tang W; Tong T; Wang H; Lu X; Yang C; Wu Y; Wang Y; Liu J; Ding B
Angew Chem Int Ed Engl; 2023 Dec; 62(51):e202315093. PubMed ID: 37906116
[TBL] [Abstract][Full Text] [Related]
6. A Genome-Editing Nanomachine Constructed with a Clustered Regularly Interspaced Short Palindromic Repeats System and Activated by Near-Infrared Illumination.
Peng H; Le C; Wu J; Li XF; Zhang H; Le XC
ACS Nano; 2020 Mar; 14(3):2817-2826. PubMed ID: 32048826
[TBL] [Abstract][Full Text] [Related]
7. Targeting RLIP with CRISPR/Cas9 controls tumor growth.
Singhal J; Chikara S; Horne D; Awasthi S; Salgia R; Singhal SS
Carcinogenesis; 2021 Feb; 42(1):48-57. PubMed ID: 32426802
[TBL] [Abstract][Full Text] [Related]
8. Persistent Targeting DNA Nanocarrier Made of 3D Structural Unit Assembled from Only One Basic Multi-Palindromic Oligonucleotide for Precise Gene Cancer Therapy.
Wu J; Zheng X; Lin W; Chen L; Wu ZS
Adv Healthc Mater; 2024 Apr; 13(11):e2303865. PubMed ID: 38289018
[TBL] [Abstract][Full Text] [Related]
9. Comparative analysis of lipid Nanoparticle-Mediated delivery of CRISPR-Cas9 RNP versus mRNA/sgRNA for gene editing in vitro and in vivo.
Walther J; Porenta D; Wilbie D; Seinen C; Benne N; Yang Q; de Jong OG; Lei Z; Mastrobattista E
Eur J Pharm Biopharm; 2024 Mar; 196():114207. PubMed ID: 38325664
[TBL] [Abstract][Full Text] [Related]
10. MicroRNA-responsive release of Cas9/sgRNA from DNA nanoflower for cytosolic protein delivery and enhanced genome editing.
Shi J; Yang X; Li Y; Wang D; Liu W; Zhang Z; Liu J; Zhang K
Biomaterials; 2020 Oct; 256():120221. PubMed ID: 32738651
[TBL] [Abstract][Full Text] [Related]
11. Effect of antisense RNA targeting Polo-like kinase 1 on cell growth in A549 lung cancer cells.
Zhou Q; Su Y; Bai M
J Huazhong Univ Sci Technolog Med Sci; 2008 Feb; 28(1):22-6. PubMed ID: 18278450
[TBL] [Abstract][Full Text] [Related]
12. Near-infrared upconversion-activated CRISPR-Cas9 system: A remote-controlled gene editing platform.
Pan Y; Yang J; Luan X; Liu X; Li X; Yang J; Huang T; Sun L; Wang Y; Lin Y; Song Y
Sci Adv; 2019 Apr; 5(4):eaav7199. PubMed ID: 30949579
[TBL] [Abstract][Full Text] [Related]
13. Gene Therapy with CRISPR/Cas9 Coming to Age for HIV Cure.
Soriano V
AIDS Rev; 2017; 19(3):167-172. PubMed ID: 29019352
[TBL] [Abstract][Full Text] [Related]
14. Thermo-triggered Release of CRISPR-Cas9 System by Lipid-Encapsulated Gold Nanoparticles for Tumor Therapy.
Wang P; Zhang L; Zheng W; Cong L; Guo Z; Xie Y; Wang L; Tang R; Feng Q; Hamada Y; Gonda K; Hu Z; Wu X; Jiang X
Angew Chem Int Ed Engl; 2018 Feb; 57(6):1491-1496. PubMed ID: 29282854
[TBL] [Abstract][Full Text] [Related]
15. Lecithin nano-liposomal particle as a CRISPR/Cas9 complex delivery system for treating type 2 diabetes.
Cho EY; Ryu JY; Lee HAR; Hong SH; Park HS; Hong KS; Park SG; Kim HP; Yoon TJ
J Nanobiotechnology; 2019 Jan; 17(1):19. PubMed ID: 30696428
[TBL] [Abstract][Full Text] [Related]
16. Graphene oxide-mediated Cas9/sgRNA delivery for efficient genome editing.
Yue H; Zhou X; Cheng M; Xing D
Nanoscale; 2018 Jan; 10(3):1063-1071. PubMed ID: 29266160
[TBL] [Abstract][Full Text] [Related]
17. Targeting cancer epigenetics with CRISPR-dCAS9: Principles and prospects.
Rahman MM; Tollefsbol TO
Methods; 2021 Mar; 187():77-91. PubMed ID: 32315755
[TBL] [Abstract][Full Text] [Related]
18. An RNA/DNA hybrid origami-based nanoplatform for efficient gene therapy.
Wu X; Liu Q; Liu F; Wu T; Shang Y; Liu J; Ding B
Nanoscale; 2021 Aug; 13(30):12848-12853. PubMed ID: 34477769
[TBL] [Abstract][Full Text] [Related]
19. Co-encapsulation of Cas9 mRNA and guide RNA in polyplex micelles enables genome editing in mouse brain.
Abbasi S; Uchida S; Toh K; Tockary TA; Dirisala A; Hayashi K; Fukushima S; Kataoka K
J Control Release; 2021 Apr; 332():260-268. PubMed ID: 33647431
[TBL] [Abstract][Full Text] [Related]
20. "Split-and-Click" sgRNA.
Taemaitree L; Shivalingam A; El-Sagheer AH; Brown T
Methods Mol Biol; 2021; 2162():61-78. PubMed ID: 32926378
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
